Bavarian Nordic A/S (BVNRY)
OTCMKTS · Delayed Price · Currency is USD
12.39
+0.05 (0.36%)
Oct 20, 2025, 1:03 PM EDT
Bavarian Nordic Revenue
Bavarian Nordic had revenue of 1.65 billion DKK in the quarter ending June 30, 2025, with 15.69% growth. This brings the company's revenue in the last twelve months to 6.46 billion, up 6.13% year-over-year. In the year 2024, Bavarian Nordic had annual revenue of 5.72 billion, down -19.06%.
Revenue (ttm)
6.46B DKK
Revenue Growth
+6.13%
P/S Ratio
2.87
Revenue / Employee
4.02M DKK
Employees
1,605
Market Cap
2.92B USD
Revenue Chart
* This company reports financials in DKK.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 5.72B | -1.35B | -19.06% |
Dec 31, 2023 | 7.06B | 3.91B | 124.14% |
Dec 31, 2022 | 3.15B | 1.25B | 66.02% |
Dec 31, 2021 | 1.90B | 45.49M | 2.46% |
Dec 31, 2020 | 1.85B | 1.19B | 179.61% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
American Oncology Network | 1.76B |
Veradigm | 588.02M |
Jushi Holdings | 256.36M |
Glass House Brands | 221.55M |
Elite Pharmaceuticals | 105.45M |
Silence Therapeutics | 27.17M |
Nuo Therapeutics | 1.95M |
Northwest Biotherapeutics | 1.09M |
Bavarian Nordic News
- 4 days ago - Bavarian Nordic's Largest Shareholder Stands Firm Against $3.1 Billion Private-Equity Takeover Bid - WSJ
- 5 days ago - The Board of Directors maintains its recommendation in supplementary statement in respect of the improved takeover offer to the shareholders of Bavarian Nordic from the consortium led by Nordic Capital and Permira - GlobeNewsWire
- 5 days ago - Bavarian Nordic (BVNRY) Secures Higher Buyout Offer - GuruFocus
- 5 days ago - Bavarian Nordic draws higher bid for take-private deal - Seeking Alpha
- 5 days ago - Nordic Capital-led consortium raises takeover price for Bavarian Nordic to $38.94 per share - Reuters
- 5 days ago - Consortium consisting of Nordic Capital and Permira increases offer price and extends offer period until 5 November 2025 in respect of the takeover offer to the shareholders of Bavarian Nordic - GlobeNewsWire
- 8 days ago - Bavarian Nordic shareholders are reminded of expiry of the offer period regarding the takeover offer from consortium consisting of Nordic Capital and Permira - GlobeNewsWire
- 11 days ago - Consortium consisting of Nordic Capital and Permira receives final regulatory approval in respect of its takeover offer to the shareholders of Bavarian Nordic - GlobeNewsWire